您的位置: 首页 > 农业专利 > 详情页

METHOD FOR TREATMENT AND PREVENTION OF ACUTE ERYTHEMA
专利权人:
ГАЛДЕРМА ФАРМА С.А. (CH)
发明人:
АНДРЕС ФИЛИППЕ (FR),ЛЁШЕ КРИСТИАН (FR),ГРЭБЕР МИХАЭЛЬ (US)
申请号:
RU2012122983/15
公开号:
RU2012122983A
申请日:
2010.10.19
申请国别(地区):
RU
年份:
2014
代理人:
摘要:
1. A method of treating acute erythema in a person in need thereof, comprising the topical use of a pharmaceutically acceptable composition comprising an effective amount of an alpha adrenergic receptor agonist or a pharmaceutically acceptable salt thereof locally in the acute erythema region of a person. The method according to claim 1, in which acute erythema is a skin condition that occurs suddenly, is unstable and manifests itself in the form of temporary reddening of the skin. The method according to claim 2, in which acute erythema is caused by sunburn, frostbite, hot burns, insect bites, physical procedures, chemical procedures, or a combination thereof. The method according to claim 3, wherein the acute erythema is caused by physical procedures selected from the group consisting of laser radiation therapy, ultraviolet radiation therapy, radiofrequency therapy, radiation therapy, light emitting diode therapy, and microdermabrasion therapy. The method according to claim 3, in which acute erythema is caused by chemical procedures selected from the group consisting of chemical skin exfoliation therapy, drug therapy, and the use of cosmetic products. The method of claim 5, wherein the chemical procedure comprises the use of a retinoid. The method according to claim 3, in which acute erythema is caused by physical and chemical procedures selected from the group consisting of tanning procedures, phototherapy, and combinations thereof. The method of claim 1, wherein the alpha adrenergic receptor agonist is an alpha-1 adrenergic receptor agonist or a pharmaceutically acceptable salt thereof. The method of claim 8, wherein the alpha adrenergic receptor agonist is1. Способ лечения острой эритемы у нуждающегося в нем человека, содержащийместное применение фармацевтически приемлемой композиции, содержащей эффективное количество агониста альфа адренергических рецепторов или его фармацевтически приемлемой соли, локально в области острой эритемы у человека.2. Способ по п.1,
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充